To determine the role of enterohepatic recirculation on its nonlinear elimination, we studied the enteral absorption of mezlocillin in rabbits. Mezlocillin was not substantially absorbed from the stomach or duodenum. We conclude that enterohepatic recirculation does not cause the dose-dependent elimination kinetics of mezlocillin.
To determine the role of enterohepatic recirculation on its nonlinear elimination, we studied the enteral absorption of mezlocillin in rabbits. Mezlocillin was not substantially absorbed from the stomach or duodenum. We conclude that enterohepatic recirculation does not cause the dose-dependent elimination kinetics of mezlocillin.
Although some investigators have evaluated mezlocillin elimination with compartmental linear kinetics, single-dose studies in normal volunteers and in patients with renal insufficiency suggest that mezlocillin excretion follows nonlinear dose dependency (1) (2) (3) . The cause of nonlinear elimination is not known. Biliary excretion may account for 25% of mezlocillin elimination. Our present study was undertaken to determine whether microbiologically active mezlocillin can be absorbed by the gastrointestinal tract, making enterohepatic recirculation a likely explanation for observed nonlinear elimination.
Sixteen New Zealand white rabbits of either sex weighing 2.0 to 3.5 kg were housed singly in metabolism cages and given free access to food and water. A no. 160 polyethylene catheter was placed in the urinary bladder of anesthetized animals through a suprapubic incision and exteriorized for connection to a plastic bag. The bladder urethral orifice was ligated to ensure total collection of the urine. The gastroduodenal junction was exposed through a right paramedian incision.
Four groups of four animals each were prepared as described above and studied. Group 1 received 1,000 mg of mezlocillin in 5 ml of 0.15% NaCl by injection with a 26-gauge needle through the gastric wall directly into the stomach. Group 2 received the same injection into the duodenum 3 cm distal to the gastroduodenal junction. Group 3 received 1,000 mg of mezlocillin dissolved in vitro in 5 ml of antibiotic-free rabbit bile injected into the duodenum 3 cm distal to the gastroduodenal junction. Group 4 received 50 to 60 ml of mezlocillin-laden bile injected into the duodenum as in group 3. Mezlocillin-laden bile given to rabbits in group 4 was obtained by collecting bile through a no. 160 polyethylene catheter placed in the gallbladder of additional rabbits rendered anuric by ureteral ligation and given repeated intravenous doses of mezlocillin. Bile obtained from these animals was assayed for mezlocillin activity, and a sufficient volume of bile was given to rabbits in group 4 to constitute a dose of 1,000 mg.
Blood samples were collected from rabbits in groups 1 to 4 before drug administration and at 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, and 24 h after drug administration. Urine samples were collected from 0 to 2, 2 to 4, 4 to 6, and 6 to 24 h after drug administration.
Mezlocillin activity was determined microbiologically by a modification of an agar well diffusion method with a spore suspension of Bacillus subtilis (Difco Laboratories) as the reference organism (4). Mezlocillin standard solution was prepared by diluting mezlocillin of certified potency in antibiotic-free rabbit serum, urine, or bile to concentrations of 40, 20, 10, 5, 2.5, 1.25, and 0.625 jg/ml. Samples to be analyzed were diluted in antibiotic-free rabbit serum, urine, or bile until concentrations were within the standard curve. The standard curve was determined by a curve-fitting program on a Hewlett-Packard 97 calculator by the method of least-squares minimization. A standard curve was prepared each time samples were assayed, and all assays were performed in triplicate. Assay variability was 7%.
Mean mezlocillin serum concentrations for all four groups are shown in Table 1 , and urinary mezlocillin excretion is displayed in Table 2 . As shown, mezlocillin enteral absorption was slight.
Although measurable serum concentrations were attained in the three groups which received a massive dose of mezlocillin injected directly into the duodenum, serum concentrations remained below 10 Ag/ml. Less than 3% of the administered drug was recovered in the urine from any of the 16 animals studied. Dose-dependent elimination kinetics are unusual for penicillins, but have been reported for mezlocillin (1, 2) . Potential causes for nonlinear excretion include saturable renal excretion, nonlinear plasma protein binding, saturable hepatic biotransformation, and enterohepatic recirculation. We conclude that in rabbits mezlocillin is not absorbed from the stomach or duodenum and that neither dissolution in bile nor hepatic metabolism renders the drug absorbable by the intestine. Enterohepatic recirculation cannot account for observed nonlinear mezlocillin elimination.
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